U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}
Status:
Investigational
Source:
J Dermatol Surg Oncol. Jun 1980;6(6):483-6.: Not Applicable Human clinical trial Completed N/A
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Conditions:

Adrenochrome is a member of a class of chemicals known as aminochromes, each one derived by the oxidation of its precursor amine. Adrenochrome was proposed for the biogenesis of schizophrenia in 1952. Since that time the adrenochrome theory has been one of the most established and discussed theories in this field. It is known, that adrenochrome is toxic to myocar-dial tissue and may be responsible for fibril-lation and sudden death under stress. Aminochrome has been suggested as a physiological preclinical model capable of inducing five of the six mechanisms of Parkinson's disease. Until now, there is no evidence that aminochrome induces glial activation related to neuroinflammation, an important mechanism involved in the loss of dopaminergic neurons, but was shown, aminochrome neuroinflammatory ability and supported the hypothesis that it might be a better PD preclinical model to find new pharmacological treatment that stop the development of this disease.